ONCOLYTICS BIOTECH INC.
Patent Owner
Stats
- 63 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Apr 04, 2017 most recent publication
Details
- 63 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 867 Total Citation Count
- Aug 13, 1997 Earliest Filing
- 24 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2012/0273,424 METHODS OF PURIFYING VIRUSES USING GEL PERMEATION CHROMATOGRAPHYApr 27, 12Nov 01, 12[C09K, C12R, C12N, B01D]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9365823 Virus clearance of neoplastic cells from mixed cellular compositionsMay 28, 13Jun 14, 16[A61K, C12N]
8658158 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virusSep 24, 12Feb 25, 14[A61K, C12N]
8609331 Use of ribozymes in the detection of adventitious agentsSep 27, 12Dec 17, 13[C07H, C12Q, A01N, C12P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0243,732 ABROGATING PROINFLAMMATORY CYTOKINE PRODUCTION DURING ONCOLYTIC REOVIRUS THERAPYAbandonedMay 21, 13Sep 19, 13[A61K]
2011/0243,890 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a VirusAbandonedMay 17, 11Oct 06, 11[A61K, C12N, A61P]
2011/0086,005 MODULATING INTERSTITIAL PRESSURE AND ONCOLYTIC VIRAL DELIVERY AND DISTRIBUTIONAbandonedMay 27, 09Apr 14, 11[A61K, A61P]
2011/0053,249 Adenoviruses Mutated In The VA Genes For Cancer TreatmentAbandonedMay 27, 10Mar 03, 11[C12N]
2009/0202,489 ADENOVIRUSES MUTATED IN THE VA GENES FOR CANCER TREATMENTAbandonedMay 31, 07Aug 13, 09[A61K, C12N, A61P]
2008/0292,594 MUTANT REOVIRUSES AND METHODS OF MAKING AND USINGAbandonedMay 21, 08Nov 27, 08[A61K, C12N, A61P, C07K]
2008/0108,052 Use of Ribozymes in the Detection of Adventitious AgentsAbandonedMar 27, 07May 08, 08[C12Q]
2008/0081,032 Method for reducing pain using oncolytic virusesAbandonedJun 01, 07Apr 03, 08[A61K, A61P]
2008/0038,822 Virus clearance of neoplastic cells from mixed cellular compositionsAbandonedMay 30, 07Feb 14, 08[C12N]
2008/0026,048 Reovirus for the treatment of cellular proliferative disordersAbandonedMay 30, 07Jan 31, 08[A61K]
2008/0014,577 Oncolytic viruses as phenotyping agents for neoplasmsAbandonedMay 30, 07Jan 17, 08[C12Q]
2007/0190,032 Use of Local Immune Suppression to Enhance Oncolytic Viral TherapyAbandonedFeb 09, 07Aug 16, 07[A61K, A61N]
2007/0071,723 In Vivo Enhancement of Immune System Recognition of Neoplasms Following Treatment with an Oncolytic Virus or Gene Therapy VectorAbandonedAug 30, 06Mar 29, 07[A61K]
2005/0214,266 Combination of transplantation and oncolytic virus treatmentAbandonedMar 10, 05Sep 29, 05[A61K, C12N]
2005/0026,289 Virus clearance of neoplastic cells from mixed cellular compositionsAbandonedAug 31, 04Feb 03, 05[A61K, C12Q, C12N]
2005/0019,308 Oncolytic viruses for the treatment of neoplasms having activated PP2A or RacAbandonedJul 06, 04Jan 27, 05[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
